Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
Harvard Business School
UBS
McKinsey
Queensland Health
Chubb
Citi
Cipla
QuintilesIMS

Generated: February 17, 2018

DrugPatentWatch Database Preview

VIVACTIL Drug Profile

« Back to Dashboard

When do Vivactil patents expire, and when can generic versions of Vivactil launch?

Vivactil is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs.

The generic ingredient in VIVACTIL is protriptyline hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Drug patent expirations by year for VIVACTIL
Medical Subject Heading (MeSH) Categories for VIVACTIL

US Patents and Regulatory Information for VIVACTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms VIVACTIL protriptyline hydrochloride TABLET;ORAL 073644-001 Aug 24, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens VIVACTIL protriptyline hydrochloride TABLET;ORAL 016012-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Odyssey Pharms VIVACTIL protriptyline hydrochloride TABLET;ORAL 073645-001 Aug 24, 1995 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens VIVACTIL protriptyline hydrochloride TABLET;ORAL 016012-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Deloitte
Baxter
AstraZeneca
Julphar
Teva
Moodys
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot